For patients with IBD, sometimes the most important part of getting well is knowing if you actually have IBD or if your ulcerative colitis is actually Crohn’s Disease etc. The process of diagnosing inflammatory bowel disease can make all the difference in the course of treatment. Furthermore, being at a higher-risk for colon cancer, cancer screening is a critical component to the health of all IBD patients. This is where a world class pathology department comes in.
Under the direction of Dr. Robert Odze, the Gastroenterology Pathology service is a leader in the understanding of IBD pathology. Dr. Odze has authored numerous papers on the topic and is a leading expert on IBD and ileocolonic pathology.
Our Gastroenterology Pathology service provides comprehensive diagnostic expertise and services relating to the pathology of disorders of the gastrointestinal tract, liver and pancreas. In addition to evaluation by conventional histology, a variety of specialized immunological and molecular tests are routinely available. The Gastroenterology Pathology service provides services for the Brigham and Women's Hospital, Dana-Farber Cancer Institute as well as national and international consultations. Active educational initiatives include daily teaching of students, residents, and fellows, as well as programs for continuing medical education.